Clinical Trial Update: A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing extended-release tramadol hydrochloride at 100 mg, 200 mg, and 300 mg to placebo for moderate-to-severe osteoarthritis pain h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE (tramadol hydrochloride)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED